Trial site
CHU Nantes-Hotel Dieu
- 14running trials
- 5closed trials
The trials here
What the 19 trials at this site are about, from their registry records.
- Conditions
- Acute myeloid leukaemia2 trials
- HIV2 trials
- Melanoma2 trials
- Multiple myeloma2 trials
- Myelodysplastic syndromes2 trials
- Ulcerative colitis2 trials
- Colorectal cancer1 trial
- Crohn's disease1 trial
- Giant cell arteritis1 trial
- Hepatitis B1 trial
- Hepatitis C1 trial
- Liver and biliary tract cancer1 trial
- and 4 more
- Phase
- Phase 37 trials
- Phase 26 trials
- Phase 11 trial
- Status
- Recruiting7 trials
- Active, not recruiting5 trials
- Completed5 trials
- Not yet recruiting2 trials
- Lead sponsor
- Janssen Research & Development, LLC4 trials
- Hoffmann-La Roche3 trials
- DatAids2 trials
- Pierre Fabre Medicament2 trials
- Abivax S.A.1 trial
- and 7 more
Running trials
Recruiting
Recruiting
Recruiting
Not yet recruiting
Upadacitinib in Giant Cell Arteritis (GCA) With Active Large-vessel Involvement.
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Adjuvant Encorafenib and Binimetinib in High-risk Stage II Melanoma With a BRAF Mutation.
Active, not recruiting
Recruiting
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
Recruiting
Active, not recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- HIV2 recruiting
- Multiple myeloma2 recruiting
- Crohn's disease1 recruiting
- Giant cell arteritis1 recruiting
- Hepatitis C1 recruiting
- Liver and biliary tract cancer1 recruiting
- Lung cancer1 recruiting
- Mantle cell lymphoma1 recruiting
- Melanoma1 recruiting
Closed trials
Completed
Study to Evaluate Imetelstat in Patients With High-Risk MDS or AML Failing HMA-based Therapy
Completed
Completed
BST-236 as a Single Agent in Adults With Relapsed or Refractory AML or HR-MDS
Completed
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026